Preliminary analyses in different cognitive groups demonstrated that the reduced CSF complement peptides C1q, C2, C5, and CFB were associated with longitudinal brain atrophy (i.e., ventricles, whole brain, middle temporal lobe, or fusiform gyrus) and cognitive decline in MCI participants. The gene discussed is C5; the disease is Brain atrophy.